Breaking News
Sort by:
Top Post
Roche’s Tecentriq Plus Avastin Reduced Risk of Cancer Returning in People with Certain Types of Adjuvant Liver Cancer in a Phase III Study
Roche has announced new data from the Phase III IMbrave050 study that show Tecentriq (atezolizumab) […]
Ai-powered Drug Discovery Company Healx Opens New Labs at Chesterford Research Park
Healx, the AI-powered, patient-inspired technology company pioneering the next generation of drug discovery for rare […]
ABL Partners With KaliVir Immunotherapeutics to Advance Development of Oncolytic Viruses
ABL, a pure play Contract Development and Manufacturing Organization (CDMO) specialized in the development and […]
Tampa General Hospital Offers New Treatment Option for Recurrent Brain Cancer to Improve Quality of Life
Tampa General Hospital and USF Health Morsani College of Medicine physicians are the first in Hillsborough County to bring patients […]
New Early Breast Cancer Drug to Reduce Risk of Recurrence or Death Now Available in the Philippines
A NEW drug shown to significantly reduce the risk of cancer recurrence or death in […]
EarlySign Announces Strategic Collaboration Agreement with Roche on AI Solution for Early Detection of Lung Cancer
Medial EarlySign (earlysign.com), a pioneering company developing Artificial Intelligence (AI) based clinical predictive analytics, announced today […]
FUJIFILM Healthcare Europe Launches a Dedicated Prostate Fusion Imaging Platform
FUJIFILM Healthcare Europe is pleased to have unveiled the ARIETTA™ 65 IntuitiveFusion, a diagnostic ultrasound […]
Azra AI Expands Innovative Incidental Findings Technology to Help Clinicians Identify More Cancers
Azra AI‘s proprietary software — which uses artificial intelligence (AI) and natural language processing to […]
Researchers Create a Single-cell Framework to Potentially Enhance CAR T-cell Therapy
St. Jude Children’s Research Hospital scientists have demonstrated that the long-term performance of cancer-killing chimeric […]
Skyhawk Announces Collaboration Agreement with Sanofi for Oncology and Immunology Targets
Skyhawk Therapeutics, Inc. today announced the signing of an exclusive worldwide collaboration agreement with Sanofi […]
Enosi Therapeutics Partners with Danuo Science Group to Accelerate Multiple Therapeutic Programs
Enosi Therapeutics, a Delaware Corporation, focused on providing industry-leading therapeutics for cancer and autoimmune diseases, […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more